Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03824366 · ClinicalTrials.gov registry record · NA
Same-session MR-only Simulation and Treatment With MRI-guided Adaptive Palliative RadioTherapy
A NA study, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT03824366 is a NA study that has completed, run by Washington University School of Medicine. The registered enrollment target is 20 participants.
The verdict
NCT03824366, a NA study, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
This proposed study is unique in that patients will not undergo computed tomography (CT) simulation at any point during their treatment course and will instead have same-session magnetic resonance (MR)-only simulation and treatment planning, on-table, using the adaptive radiotherapy (ART) workflow. In this manner, patients requiring urgent treatment could initiate treatment as early as the day of initial radiation oncology consultation.
Interventions
- RADIATION Radiation therapy
- DEVICE Volumetric MR imaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2019-04-23 |
| Est. Completion | 2022-01-14 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03824366
The ClinicalTrials.gov registry entry for NCT03824366 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Radiation therapy is the first listed.
NCT03824366 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03824366 about?
NCT03824366 is a clinical study titled "Same-session MR-only Simulation and Treatment With MRI-guided Adaptive Palliative RadioTherapy". This proposed study is unique in that patients will not undergo computed tomography (CT) simulation at any point during their treatment course and will instead have same-session magnetic resonance (MR)-only simulation and treatment planning, on-table, using the adaptive radiotherapy (ART) workflow. ...
What is the current status of trial NCT03824366?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2019-04-23. Estimated completion is 2022-01-14.
What interventions are being tested in trial NCT03824366?
The interventions under investigation include: Radiation therapy (RADIATION), Volumetric MR imaging (DEVICE).
Who is sponsoring clinical trial NCT03824366?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.